Do We Know the Minimal Clinically Important Difference (MCID) for COPD Exacerbations?

By Chapman Kenneth R.  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 10, Iss. 2, 2013-03 ,pp. : 243-249

Informa Healthcare

Access to resources Recommend Favorite

3-chlorotyrosine in Sputum of COPD Patients: Relationship with Airway Inflammation

By O’Donnell Charles   Newbold Paul   White Peter   Thong Bob   Stone Helen   Stockley Robert A.  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 7, Iss. 6, 2010-12 ,pp. : 411-417

Informa Healthcare

Access to resources Recommend Favorite

Are We Aware of Restless Legs Syndrome in COPD Patients Who Are in an Exacerbation Period?? Frequency and Probable Factors Related to Underlying Mechanism

By Aras Gulfidan   Kadakal Figen   Purisa Sevim   Kanmaz Dilek   Aynaci Aysun   Isik Elvan  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 8, Iss. 6, 2011-12 ,pp. : 437-443

Informa Healthcare

Access to resources Recommend Favorite

Pleiotropic effects of statins in inflammation: friend or foe in human arthritis?

By Amin Ashok R  

Future Rheumatology, Vol. 3, Iss. 4, 2008-08 ,pp. : 325-328

Future Medicine

Access to resources Recommend Favorite

Macrophage infiltration and cytokine release in adipose tissue: angiogenesis or inflammation?

By Wu Lindsay  

Diabetology International, Vol. 1, Iss. 1, 2010-09 ,pp. : 26-34

Springer Publishing Company

Access to resources Recommend Favorite